Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Sep 12;2012(9):CD003397.
doi: 10.1002/14651858.CD003397.pub2.

Maternal glucose administration for facilitating tests of fetal wellbeing

Kelvin H Tan  1 , Antoinette Sabapathy
Affiliations
Meta-Analysis

Maternal glucose administration for facilitating tests of fetal wellbeing

Kelvin H Tan et al. Cochrane Database Syst Rev. .

Abstract

Background: Antenatal maternal glucose administration has been suggested to improve the efficiency of antepartum fetal heart rate testing.

Objectives: The objective of this review was to assess the merits or adverse effects of antenatal maternal glucose administration in conjunction with tests of fetal wellbeing.

Search methods: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (6 July 2012).

Selection criteria: All published and unpublished randomized controlled trials assessing the merits of antenatal maternal (oral or intravenous) glucose administration in conjunction with tests of fetal wellbeing.

Data collection and analysis: Both review authors independently extracted data and assessed trial quality. Authors of published and unpublished trials were contacted for further information.

Main results: A total of two trials, involving 708 participants, were included. Antenatal maternal glucose administration did not decrease the incidence of non-reactive antenatal cardiotocography tests.

Authors' conclusions: Antenatal maternal glucose administration has not been shown to reduce non-reactive cardiotocography. More trials are needed to further substantiate this and to determine not only the optimum dose, but also to evaluate the efficacy, predictive reliability, safety and perinatal outcome of glucose administration in conjunction with cardiotocography and also other tests of fetal wellbeing.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1.1
1.1. Analysis
Comparison 1 Maternal glucose administration versus placebo or no administration, Outcome 1 Non‐reactive cardiotocography.
1.2
1.2. Analysis
Comparison 1 Maternal glucose administration versus placebo or no administration, Outcome 2 Non‐reactive cardiotocography in fasted patients.
1.3
1.3. Analysis
Comparison 1 Maternal glucose administration versus placebo or no administration, Outcome 3 Non‐reactive cardiotocography in fed patients.
1.5
1.5. Analysis
Comparison 1 Maternal glucose administration versus placebo or no administration, Outcome 5 Perinatal deaths.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

References

References to studies included in this review

Eglinton 1984 {published data only}
    1. Eglinton GS, Paul RH, Broussard PM, Walla CA, Platt LD. Antepartum fetal heart rate testing. XI. Stimulation with orange juice. American Journal of Obstetrics and Gynecology 1984;150:97‐9. - PubMed
Richardson 1983 {published data only}
    1. Richardson B, Briggs ML, Toomey C, Burry KJ, O'Grady JP. The effect of maternal glucose administration on the specificity of the nonstress test. American Journal of Obstetrics and Gynecology 1983;145:141‐6. - PubMed

References to studies excluded from this review

Bocking 1982 {published data only}
    1. Bocking A, Adamson L, Cousin A, Campbell K, Carmichael L, Natale R, et al. Effects of intravenous glucose injections on human fetal breathing movements and gross fetal body movements at 38 to 40 weeks' gestational age. American Journal of Obstetrics and Gynecology 1982;142:606‐11. - PubMed
Bocking 1984 {published data only}
    1. Bocking A, Adamson L, Carmichael L, Patrick J, Probert C. Effect of intravenous glucose injection on human maternal and fetal heart rate at term. American Journal of Obstetrics and Gynecology 1984;148:414‐20. - PubMed
Devoe 1986 {published data only}
    1. Devoe L, Searle N, Castillo R, Searle J. The effects of maternal administration of trytophane and glucose on fetal trunk movements and fetal heart rate. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:44.
    1. Devoe LD, Castillo RA, Searle NS, Searle JR. Maternal dietary substrates and human fetal biophysical activity. I. The effects of tryptophan and glucose on fetal breathing movements. American Journal of Obstetrics and Gynecology 1986;155:135‐9. - PubMed
Devoe 1987 {published data only}
    1. Devoe LD, Searle N, Castillo RA, Searle J. Fetal biophysical testing. The effects of prolonged maternal fasting and the oral glucose tolerance test. Journal of Reproductive Medicine 1987;32:563‐8. - PubMed
Gelman 1980 {published data only}
    1. Gelman SR, Spellacy WN, Wood S, Birk SA, Buhi WC. Fetal movements and ultrasound: effect of maternal intravenous glucose administration. American Journal of Obstetrics and Gynecology 1980;137:459‐61. - PubMed
Lewis 1978 {published data only}
    1. Lewis PJ, Trudinger BJ, Mangez J. Effect of maternal glucose ingestion on fetal breathing and body movements in late pregnancy. British Journal of Obstetrics and Gynaecology 1978;85:86‐9. - PubMed
Natale 1983 {published data only}
    1. Natale R, Richardson B, Patrick J. The effect of maternal hyperglycemia on gross body movements in human fetuses at 32‐34 weeks' gestation. Early Human Development 1983;8:13‐20. - PubMed
Neldam 1982 {published data only}
    1. Neldam S, Hornnes PJ, Kuhl C. Effect of maternal triglyceride ingestion on fetal respiratory movements. Obstetrics & Gynecology 1982;59:640‐2. - PubMed
Nijhuis 1986 {published data only}
    1. Nijhuis JG, Jongsma HW, Crijns IJMJ, Valk IMGM, Velden JWHJ. Effects of maternal glucose ingestion on human fetal breathing movements at weeks 24 and 28 of gestation. Early Human Development 1986;13:183‐8. - PubMed

Additional references

Adadjem 1979
    1. Adadjem S, Feria A, Rest J, Gull K, O'Connor M. Effect of maternal glucose load on fetal activity. American Journal of Obstetrics and Gynecology 1979;134:276. - PubMed
Clarke 2000
    1. Clarke M, Oxman AD, editors. Cochrane Reviewers’ Handbook 4.1 [updated June 2000]. In: Review Manager (RevMan) [Computer program]. Version 4.1. Oxford, England: The Cochrane Collaboration, 2000.
Egger 1997
    1. Egger M, Smith GD, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315:629‐34. - PMC - PubMed
Harbord 2006
    1. Harbord RM, Egger M, Sterne JA. A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine 2006 2006;25:3443‐57. - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Miller 1978
    1. Miller FC, Skiba H, Klapholz H. The effect of maternal blood sugar levels on fetal activity. Obstetrics & Gynecology 1978;52:663. - PubMed
RevMan 2000 [Computer program]
    1. The Cochrane Collaboration. Review Manager (RevMan). Version 4.1 for Windows. Oxford, England: The Cochrane Collaboration, 2000.
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.

LinkOut - more resources